Literature DB >> 1962075

Experimental leishmaniasis in humans: review.

P C Melby1.   

Abstract

Experimental infection of humans with Leishmania parasites has contributed significantly to the understanding of the etiology, transmission, and pathogenesis of leishmaniasis and the immunity associated with it. Leishmania organisms recovered from human and animal tissue, insect vectors, and in vitro cultures have all produced cutaneous or visceral leishmaniasis in human subjects who were voluntarily inoculated with them. Volunteers bitten by infected Phlebotomine sandflies also developed cutaneous or visceral disease. In these experiments, it appeared that the parasite must undergo certain developmental changes within the sandfly for it to become infective and that the parasites in sandflies were far more efficient in causing full-blown infection than were cultured Leishmania organisms. The clinical manifestations of these experimental infections did not differ from infections that were acquired naturally. Natural or experimental infections appeared to confer resistance to subsequent leishmanial infection. This immunity was best documented to be a species-specific phenomenon; however, a small number of studies have demonstrated cross protection between some Leishmania species. In this review article, data from human experimental infections are summarized and discussed in light of recent advances in the field.

Entities:  

Mesh:

Year:  1991        PMID: 1962075     DOI: 10.1093/clinids/13.5.1009

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  17 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.

Authors:  Audrey Romano; Nicole A Doria; Jonatan Mendez; David L Sacks; Nathan C Peters
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

3.  Urban transmission of American cutaneous leishmaniasis in Argentina: spatial analysis study.

Authors:  José F Gil; Julio R Nasser; Silvana P Cajal; Marisa Juarez; Norma Acosta; Rubén O Cimino; Patricio Diosque; Alejandro J Krolewiecki
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

4.  Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.

Authors:  S Farajnia; F Mahboudi; S Ajdari; N E Reiner; A Kariminia; M H Alimohammadian
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

5.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Restricted outbreak of American tegumentary leishmaniasis with high microfocal transmission.

Authors:  Alejandro J Krolewiecki; José F Gil; Marcelo Quipildor; Silvana P Cajal; Carlos Pravia; Marisa Juarez; Carlos Villalpando; Fabricio M Locatelli; Mariana Chanampa; Gabriela Castillo; María F Oreste; Carlos L Hoyos; Vanesa Negri; Julio R Nasser
Journal:  Am J Trop Med Hyg       Date:  2013-01-21       Impact factor: 2.345

7.  Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.

Authors:  S Rafati; S Couty-Jouve; M H Alimohammadian; J A Louis
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

8.  A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

Authors:  M E Wilson; B M Young; K P Andersen; J V Weinstock; A Metwali; K M Ali; J E Donelson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  First report of Leishmania infantum in French Guiana: canine visceral leishmaniasis imported from the Old World.

Authors:  Brice Rotureau; Christophe Ravel; Christine Aznar; Bernard Carme; Jean-Pierre Dedet
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.

Authors:  Asha Jayakumar; Robyn Widenmaier; Xiaojing Ma; Mary Ann McDowell
Journal:  J Parasitol       Date:  2008-02       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.